Technical and Diagnostic Performance of 6 Assays for the Measurement of Citrullinated Protein/Peptide Antibodies in the Diagnosis of Rheumatoid Arthritis

This publication has 35 references indexed in Scilit:

• Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review
  Annals of the Rheumatic Diseases, 2006
• The effect of etanercept on anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis
  Annals of the Rheumatic Diseases, 2006
• Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis
  Annals of the Rheumatic Diseases, 2005
• Association of rheumatoid arthritis treatment response and disease duration with declines in serum levels of IgM rheumatoid factor and anti–cyclic citrullinated peptide antibody
  Arthritis & Rheumatism, 2004
• Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFα therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement
  Annals of the Rheumatic Diseases, 2004
• Detection of antibodies to deiminated recombinant rat filaggrin by enzyme‐linked immunosorbent assay: A highly effective test for the diagnosis of rheumatoid arthritis
  Arthritis & Rheumatism, 2002
• Clinical Assessment of the 1987 American College of Rheumatology Criteria for Rheumatoid Arthritis
  Scandinavian Journal of Rheumatology, 1996
• The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis.
  Journal of Clinical Investigation, 1993
• The rheumatoid factor: An analysis of clinical utility
  The American Journal of Medicine, 1991
• The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis
  Arthritis & Rheumatism, 1988